Never miss the latest news and offers - subscribe now!
As gene therapies move toward commercialization, the journey to manufacture a high-quality product while achieving economies of scale and reducing facility footprint can be challenging. Developing and optimizing your process development early on is critical for your company’s long-term success.
In this webinar, we will present case studies illustrating the benefits of leveraging industry experts, proven methods, and integrated bioprocess solutions to increase your speed to market while driving down manufacturing cost and risk. You will hear from Pall’s Accelerator℠ process development experts on their approach to the industry’s most pressing challenges.
Attendees will learn how to:
- Achieve versatility with an automated, single-use end-to-end platform
- Optimize small-scale expression systems into a scalable process
- Achieve goals faster and better through collaboration
Case studies of Adeno-Associated Virus (AAV) and Lentivirus (LV) production using adherent and suspension cell culture